|
Clinical Trials and Observations
Citations 181-190 of 2742 total displayed.
|
Past content
(since May 1998):
|
B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome
- Tait D. Shanafelt, Neil E. Kay, Greg Jenkins, Timothy G. Call, Clive S. Zent, Diane F. Jelinek, William G. Morice, Justin Boysen, Liam Zakko, Susan Schwager, Susan L. Slager, and Curtis A. Hanson
Blood 2009; 113: 4188-4196.
[Abstract]
[Full text]
[PDF]
microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia
- Aldo M. Roccaro, Antonio Sacco, Changzhong Chen, Judith Runnels, Xavier Leleu, Feda Azab, Abdel Kareem Azab, Xiaoying Jia, Hai T. Ngo, Molly R. Melhem, Nicholas Burwick, Lyuba Varticovski, Carl D. Novina, Barrett J. Rollins, Kenneth C. Anderson, and Irene M. Ghobrial
Blood 2009; 113: 4391-4402.
[Abstract]
[Full text]
[PDF]
CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
- Volkmar Boehme, Norbert Schmitz, Samira Zeynalova, Markus Loeffler, and Michael Pfreundschuh
Blood 2009; 113: 3896-3902.
[Abstract]
[Full text]
[PDF]
Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCG
- Jan Braess, Karsten Spiekermann, Peter Staib, Andreas Grüneisen, Bernhard Wörmann, Wolf-Dieter Ludwig, Hubert Serve, Albrecht Reichle, Rudolf Peceny, Daniel Oruzio, Christoph Schmid, Xaver Schiel, Marcus Hentrich, Christina Sauerland, Michael Unterhalt, Michael Fiegl, Wolfgang Kern, Christian Buske, Stefan Bohlander, Achim Heinecke, Herrad Baurmann, Dietrich W. Beelen, Wolfgang E. Berdel, Thomas Büchner, and Wolfgang Hiddemann
Blood 2009; 113: 3903-3910.
[Abstract]
[Full text]
[PDF]
Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival
- Grace H. Ku, Richard H. White, Helen K. Chew, Danielle J. Harvey, Hong Zhou, and Ted Wun
Blood 2009; 113: 3911-3917.
[Abstract]
[Full text]
[PDF]
NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study
- Vahid Asnafi, Agnès Buzyn, Sandrine Le Noir, Frédéric Baleydier, Arnauld Simon, Kheira Beldjord, Oumedaly Reman, Francis Witz, Thierry Fagot, Emmanuelle Tavernier, Pascal Turlure, Thibaut Leguay, Françoise Huguet, Jean-Paul Vernant, Francis Daniel, Marie-Christine Béné, Norbert Ifrah, Xavier Thomas, Hervé Dombret, and Elizabeth Macintyre
Blood 2009; 113: 3918-3924.
[Abstract]
[Full text]
[PDF]
Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project
- Wing-yan Au, Dennis D. Weisenburger, Tanin Intragumtornchai, Shigeo Nakamura, Won-Seog Kim, Ivy Sng, Julie Vose, James O. Armitage, Raymond Liang, and for the International Peripheral T-Cell Lymphoma Project
Blood 2009; 113: 3931-3937.
[Abstract]
[Full text]
[PDF]
A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response
- Keith W. Pratz, Jorge Cortes, Gail J. Roboz, Niranjan Rao, Omotayo Arowojolu, Adam Stine, Yukimasa Shiotsu, Aiko Shudo, Shiro Akinaga, Donald Small, Judith E. Karp, and Mark Levis
Blood 2009; 113: 3938-3946.
[Abstract]
[Full text]
[PDF]
Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study
- Lionel Adès, Simone Boehrer, Thomas Prebet, Odile Beyne-Rauzy, Laurence Legros, Christophe Ravoet, François Dreyfus, Aspasia Stamatoullas, Marie Pierre Chaury, Jacques Delaunay, Guy Laurent, Norbert Vey, Sara Burcheri, Rose-Marie Mbida, Natacha Hoarau, Claude Gardin, and Pierre Fenaux
Blood 2009; 113: 3947-3952.
[Abstract]
[Full text]
[PDF]
Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control
- April L. Ferre, Peter W. Hunt, J. William Critchfield, Delandy H. Young, Megan M. Morris, Juan C. Garcia, Richard B. Pollard, Hal F. Yee, Jr, Jeffrey N. Martin, Steven G. Deeks, and Barbara L. Shacklett
Blood 2009; 113: 3978-3989.
[Abstract]
[Full text]
[PDF]
|
|
